Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …

Primary liver cancer, the majority of which are hepatocellular carcinomas, is now the second
leading cause of cancer death worldwide. Hepatocellular carcinoma is a unique cancer that …

Background & Aims HDV infection causes severe chronic liver disease in individuals
infected with HBV. However, the factors associated with poor prognosis are largely …

Hepatitis delta virus (HDV) is a defective virus and a satellite of the hepatitis B virus (HBV).
Its RNA genome is unique among animal viruses, but it shares common features with some …

Background Therapies for chronic hepatitis delta virus (HDV) infection are unsatisfactory.
Prenylation is essential for HDV and inhibition abrogates HDV production in experimental …

Abstract Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer
deaths in the United States alone. The public health burden associated with these numbers …

Among adults in the 2011-2016 National Health and Nutrition Examination Survey
(NHANES), the estimated prevalence of hepatitis B surface antigen (HBsAg) was 0.36 …

Hepatitis delta virus (HDV) is a defective virus that requires the hepatitis B virus (HBV) to
complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating …

Background and Aims Hepatitis delta virus (HDV) infection is associated with fast
progression to liver cirrhosis and liver complications. Previous studies have, however, been …

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the second
leading cause of cancer deaths globally. The high prevalence of HCC is due in part to the …